Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1554-1560

  Zhang, Wen ^a   Braun, Aaron ^a   Bauman, Zachary ^a   Olteanu, Horatiu ^a   Madzelan, Peter ^a   Banerjee, Ruma ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTEINE; CYTOCHROME P450 REDUCTASE; METHIONINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

AMINO ACID SYNTHESIS; ARTICLE; BREAST CANCER; CELL TYPE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; CELL LINE, TUMOR; CYSTATHIONINE BETA-SYNTHASE; FERREDOXIN-NADP REDUCTASE; GENE EXPRESSION PROFILING; HOMOCYSTEINE; HUMANS; METHIONINE; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEOPLASMS;

EID: 13944262493     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1554     Document Type: Article

References (44)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
2. Hsieh CL, Jones PA. Meddling with methylation. Nat Cell Biol 2003;5:502-4.
3. Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 1984;738:49-87.
4. El-Osta A. DNMT cooperativity-the developing links between methylation, chromatin structure and cancer. BioEssays 2003;25:1071-84.
5. Jeanpierre M, Turleau C, Aurias A, et al. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet 1993;2:731-5.
6. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-9.
7. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994;91:9700-4.
8. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-37.
9. Hoffman RM. Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease. Hum Cell 1997;10:69-80.
10. Tang B, Li YN, Kruger WD. Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth. Cancer Res 2000;60:5543-7.
11. van der Put NMJ, van der Molen EF, Kluijtmans LAG, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinemia in neural-tube defects and vascular disease. Q J Med 1997;90:511-7.
12. Frosst P, Blom JJ, Milos R, et al. A Candidate Genetic Risk Factor for Vascular Disease: A Common Mutation in Methylenetetrahydrofolate Reductase [letter]. Nat Genet 1995;10:111-3.
13. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
14. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet 1996;59:1262-7.
15. Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002;62:4519-24.
16. Linnebank M, Schmidt S, Kolsch H, et al. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 2004;90:1969-71.
17. Gemmati D, Ongaro A, Scapoli GL, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004;13: 787-94.
18. Ge Y, Jensen T, James SJ, et al. High frequency of the 844ins68 cystathionine-β-synthase gene variant in Down syndrome children with acute myeloid leukemia. Leukemia 2002;16:2339-41.
19. Goode EL, Potter JD, Bigler J, Ulrich CM. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004;13:157-62.
20. Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P450 reductase-like dual flavoprotein, is sufficient for methionine synthase activation. J Biol Chem 2001;276:35558-63.
21. Monks A, Scudiero D, Skehan P, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757-66.
22. Fitzsimmons SA, Workman P, Grever M, Paull K, Camalier R, Lewis AD. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 1996;88:259-69.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
24. 12. BBRC 1999;259:436-42.
25. Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000;39:13005-11.
26. Stinson SF, Alley MC, Kopp WC, et al. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res 1992;12:1035-53.
27. Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 1983;117:429-34.
28. Hoffman RM. Methionine dependence in cancer cells - a review. In Vitro 1982;18:421-8.
29. 12. J Biol Chem 2003;278:20778-84.
30. Sekhon J, Pereira P, Sabbaghian N, Schievella AR, Rozen R. Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumor lines. Br J Cancer 2002;87:225-30.
31. Swanson DA, Liu ML, Baker PJ, et al. Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol 2001;21:1058-65.
32. Lu S, Epner DE. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 2000;38:123-30.
33. Hoffman RM, Erbe RW. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A 1976;73:1523-7.
34. Paine MJ, Garner AP, Powell D, et al. Cloning and characterization of a novel human dual flavin reductase. J Biol Chem 2000;275:1471-8.
35. Coalson DW, Mecham JO, Stern PH, Hoffman RM. Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. Proc Natl Acad Sci U S A 1982;79:4248-51.
36. Hoshiya Y, Guo H, Kubota T, et al. Human tumors are methionine dependent in vivo. Anticancer Res 1995;15:717-8.
37. Mineura K, Sasajima T, Sasajima H, Kowada M. Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumors. Int J Cancer 1996;67:681-3.
38. Cellarier E, Durando X, Vasson MP, et al. Methionine dependency and cancer treatment. Cancer Treat Rev 2003;29:489-99.
39. Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 2003;100:14229-34.
40. Tisdale MJ. Utilization of preformed and endogenously synthesized methionine by cells in tissue culture. Br J Cancer 1984;49:315-20.
41. Hoffman RM. Altered methionine metabolism and transmethylation in cancer. Anticancer Res 1985;5:1-30.
42. Liteplo RG, Hipwell SE, Rosenblatt DS, Sillaots S, Lue-Shing H. Changes in cobalamin metabolism are associated with the altered methionine auxotrophy of highly growth autonomous human melanoma cells. J Cell Physiol 1991;149:332-8.
43. Yamada K, Kawata T, Wada M, et al. Extremely low activity of methionine synthase in vitamin B-12-deficient rats may be related to effects on coenzyme stabilization rather than to changes in coenzyme induction. J Nutr 2000;130:1894-900.
44. McGuire JJ. Anticancer antifolates: current status and future directions. Curr Pharm Des 2003;9:2593-613.